Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2006-07-14
2011-12-13
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C514S620000
Reexamination Certificate
active
08076514
ABSTRACT:
The present invention is directed to compounds of formula (I) or a pharmaceutically acceptable salt thereof; wherein A is (xx); X is selected from CH, CF and N, R5 is selected from H, C1-C6alkyl, C1-C6fluoroalkyl, and —OR12, R9 is selected from H and —C(O)NR1OR1 1, R12 is selected from H, C1-C6alkyl and C3-C6cycloalkyl for use as inhibitors of the DPP-IV enzyme in the treatment or prevention of conditions including Type II diabetes.
REFERENCES:
patent: 5508407 (1996-04-01), Kaldor
patent: 5554653 (1996-09-01), Hui et al.
patent: 5714142 (1998-02-01), Blaney et al.
patent: 2004/0167133 (2004-08-01), Edmondson et al.
patent: 2004/0236102 (2004-11-01), Brockunier et al.
patent: 526009 (1993-02-01), None
patent: 604184 (1994-06-01), None
patent: WO 95/09843 (1995-04-01), None
patent: WO 96/41795 (1996-12-01), None
patent: WO 03/000181 (2003-01-01), None
patent: WO 03/004498 (2003-01-01), None
patent: WO 03/082817 (2003-01-01), None
patent: WO 03/034989 (2003-05-01), None
patent: WO 2004/037169 (2004-05-01), None
patent: WO 2007/015767 (2007-02-01), None
patent: WO 2007/015805 (2007-02-01), None
RN 177739-96-7(corresponding to US 5,508,407, 1996.
Yuichi Kanoaka et al., “Application of the Robinson Dehydrogenation Reaction”, Chemical and Pharmaceutical Bulletin, 1959(5), 589-594, XP008071731.
Xu J et al., “Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors”, Bioorganic & Medicinal Chemistry Letters, 15(10), 2533-2536, ISNN: 0960-894X, XP004877719.
C. Rummey et al, “In silico fragment-based discovery of DPP-IV S1 pocket binders”, Bioorganic & Medicinal Chemistry Letters 16 (2006) pp. 1405-1409.
J. Peters et al, “Aminomethylpyrimidines as novel DPP-IV inhibitors: A 105-fold activity increase by optimization of aromatic substituents”, Bioorganic & Medicinal Chemistry Letters 14 (2004), pp. 1491-1493.
Blaszczak Larry Chris
Pulley Shon Roland
Robertson Michael Alan
Sheehan Scott Martin
Shi Qing
Eli Lilly and Company
Kumar Shailendra
Myers James B.
LandOfFree
Phenyl compounds and their use in the treatment of Type II... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl compounds and their use in the treatment of Type II..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl compounds and their use in the treatment of Type II... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4261291